GE Healthcare Medical Diagnostics Reintroduces Optison Ultrasound Contrast Agent for Echocardiograms

GE Healthcare Medical Diagnostics reintroduces Optison ultrasound contrast agent for echocardiograms
GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms. Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular …
Read more on News-Medical-Net

Purple drink popularity grows in NFL circles
Arrest of former Oakland QB brings attention
Read more on The Biloxi Sun Herald